Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $116,555 | 59 | 45.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $79,850 | 24 | 31.3% |
| Honoraria | $27,877 | 9 | 10.9% |
| Travel and Lodging | $12,062 | 38 | 4.7% |
| Unspecified | $9,070 | 5 | 3.6% |
| Food and Beverage | $4,803 | 77 | 1.9% |
| Compensation for serving as faculty or as a speaker for a medical education program | $3,850 | 1 | 1.5% |
| Grant | $1,205 | 1 | 0.5% |
| Education | $218.45 | 4 | 0.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $124,731 | 74 | $0 (2024) |
| UCB, Inc. | $36,566 | 33 | $0 (2024) |
| Lilly USA, LLC | $16,549 | 8 | $0 (2023) |
| Eli Lilly and Company | $13,829 | 6 | $0 (2023) |
| Aclaris Therapeutics, Inc. | $10,130 | 11 | $0 (2019) |
| Incyte Corporation | $8,871 | 10 | $0 (2023) |
| Janssen Biotech, Inc. | $8,790 | 13 | $0 (2024) |
| GENZYME CORPORATION | $5,385 | 7 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $4,673 | 4 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $4,126 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $40,475 | 38 | PFIZER INC. ($25,684) |
| 2023 | $74,411 | 47 | PFIZER INC. ($24,134) |
| 2022 | $47,133 | 40 | UCB, Inc. ($16,010) |
| 2021 | $29,982 | 16 | PFIZER INC. ($17,572) |
| 2020 | $35,100 | 20 | PFIZER INC. ($30,900) |
| 2019 | $22,543 | 32 | PFIZER INC. ($10,673) |
| 2018 | $3,992 | 13 | Galderma Laboratories, L.P. ($1,977) |
| 2017 | $1,854 | 12 | Allergan Inc. ($1,490) |
All Payment Transactions
218 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/24/2024 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Consulting Fee | Cash or cash equivalent | $1,700.00 | General |
| Category: Immunology | ||||||
| 09/16/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
| Category: Dermatology | ||||||
| 09/14/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $106.77 | General |
| 08/13/2024 | UCB, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,075.00 | General |
| 07/08/2024 | PFIZER INC. | LITFULO (Drug) | Consulting Fee | Cash or cash equivalent | $1,890.00 | General |
| Category: IMMUNOLOGY | ||||||
| 07/02/2024 | UCB, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,000.00 | General |
| 07/02/2024 | UCB, Inc. | — | Travel and Lodging | Cash or cash equivalent | $32.28 | General |
| 07/02/2024 | UCB, Inc. | — | Travel and Lodging | Cash or cash equivalent | $22.98 | General |
| 06/26/2024 | PFIZER INC. | CIBINQO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,310.00 | General |
| Category: Inflammation & Immunology | ||||||
| 06/17/2024 | PFIZER INC. | LITFULO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,500.00 | General |
| Category: IMMUNOLOGY | ||||||
| 06/11/2024 | PFIZER INC. | LITFULO (Drug) | Honoraria | Cash or cash equivalent | $1,260.00 | General |
| Category: IMMUNOLOGY | ||||||
| 06/11/2024 | UCB, Inc. | — | Travel and Lodging | In-kind items and services | $456.20 | General |
| 06/10/2024 | PFIZER INC. | CIBINQO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,285.00 | General |
| Category: Inflammation & Immunology | ||||||
| 06/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 06/06/2024 | UCB, Inc. | — | Travel and Lodging | In-kind items and services | $45.00 | General |
| 05/17/2024 | PFIZER INC. | CIBINQO (Drug) | Travel and Lodging | In-kind items and services | $640.40 | General |
| Category: Inflammation & Immunology | ||||||
| 05/17/2024 | PFIZER INC. | CIBINQO (Drug) | Travel and Lodging | In-kind items and services | $460.74 | General |
| Category: Inflammation & Immunology | ||||||
| 05/17/2024 | PFIZER INC. | CIBINQO (Drug) | Travel and Lodging | In-kind items and services | $449.87 | General |
| Category: Inflammation & Immunology | ||||||
| 05/17/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $216.12 | General |
| Category: Inflammation & Immunology | ||||||
| 05/17/2024 | PFIZER INC. | LITFULO (Drug) | Food and Beverage | In-kind items and services | $51.78 | General |
| Category: IMMUNOLOGY | ||||||
| 05/10/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $506.25 | General |
| 05/09/2024 | PFIZER INC. | LITFULO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,500.00 | General |
| Category: IMMUNOLOGY | ||||||
| 05/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: Immunology | ||||||
| 05/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $27.37 | General |
| Category: Immunology | ||||||
| 04/26/2024 | UCB, Inc. | — | Travel and Lodging | In-kind items and services | $60.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RITLECITINIB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $4,600 | 2 |
| ABROCITINIB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $4,470 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 534 | 757 | $97,514 | $24,146 |
| 2022 | 10 | 487 | 750 | $99,910 | $25,368 |
| 2021 | 8 | 441 | 607 | $83,344 | $20,931 |
| 2020 | 9 | 509 | 779 | $85,352 | $20,232 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 169 | 188 | $27,174 | $8,379 | 30.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 115 | 131 | $28,925 | $8,156 | 28.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 69 | 79 | $14,770 | $2,740 | 18.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 43 | 43 | $9,596 | $2,260 | 23.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 22 | 23 | $5,313 | $1,033 | 19.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 51 | 52 | $7,328 | $977.70 | 13.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 51 | 226 | $2,721 | $324.53 | 11.9% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 14 | 15 | $1,687 | $275.53 | 16.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 123 | 154 | $33,946 | $10,211 | 30.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 127 | 146 | $20,928 | $6,595 | 31.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 58 | 74 | $13,802 | $2,391 | 17.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $6,588 | $1,748 | 26.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 29 | 29 | $6,548 | $1,590 | 24.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 30 | 32 | $7,692 | $1,295 | 16.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 28 | 29 | $3,973 | $529.61 | 13.3% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 20 | 26 | $2,864 | $458.67 | 16.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 43 | 231 | $2,799 | $320.87 | 11.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 11 | $770.00 | $227.48 | 29.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 108 | 121 | $26,623 | $7,875 | 29.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 134 | 149 | $21,653 | $6,661 | 30.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 33 | 33 | $7,290 | $2,120 | 29.1% |
| 17000 | Destruction of skin growth | Office | 2021 | 54 | 64 | $12,018 | $1,968 | 16.4% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 22 | 22 | $5,382 | $855.54 | 15.9% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 30 | 34 | $5,066 | $645.58 | 12.7% |
| 11900 | Injection of up to 7 skin growths | Office | 2021 | 22 | 30 | $3,374 | $565.71 | 16.8% |
About Dr. Amy Mcmichael, MD
Dr. Amy Mcmichael, MD is a Dermatology healthcare provider based in Winston Salem, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1134104177.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Mcmichael, MD has received a total of $255,490 in payments from pharmaceutical and medical device companies, with $40,475 received in 2024. These payments were reported across 218 transactions from 25 companies. The most common payment nature is "Consulting Fee" ($116,555).
As a Medicare-enrolled provider, Mcmichael has provided services to 1,971 Medicare beneficiaries, totaling 2,893 services with total Medicare billing of $90,676. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Winston Salem, NC
- Active Since 12/13/2005
- Last Updated 10/21/2010
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1134104177
Products in Payments
- CIBINQO (Drug) $20,610
- LITFULO (Drug) $14,776
- TREMFYA (Drug) $12,902
- OPZELURA (Drug) $8,471
- DUPIXENT (Biological) $7,602
- ESKATA (Drug) $5,510
- Zoryve (Drug) $2,273
- SKYRIZI (Biological) $2,025
- ORACEA (Drug) $321.82
- Humira (Biological) $302.81
- Sotyktu (Drug) $152.77
- Erivedge (Biological) $118.75
- EPIDUO FORTE (Drug) $103.13
- DUPIXENT DUPILUMAB INJECTION (Biological) $80.84
- BOTOX (Biological) $75.95
- RINVOQ (Biological) $34.39
- Winlevi (Drug) $32.00
- Impoyz (Drug) $26.99
- EUCRISA (Drug) $23.60
- CRESEMBA (Drug) $17.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Winston Salem
Steven Feldman, Md, MD
Dermatology — Payments: $4.3M
Joseph Jorizzo, Md, MD
Dermatology — Payments: $74,535
Dr. Kevin Stein, M.d, M.D
Dermatology — Payments: $29,793
Rita Pichardo, Md, MD
Dermatology — Payments: $29,715
Camille Roberts, Md, MD
Dermatology — Payments: $4,154
Christine Ahn, Md, MD
Dermatology — Payments: $2,818